Abstract
BACKGROUND: Production of antibodies that are specific for allergens is an important pathological process in inflammatory allergic diseases. These contain the antibodies against antigens of Candida albicans, one of the normal microbial flora in an intestinal tract. We studied the effects of the prednisolone administration on the production of anti-Candida antibodies in the gastrointestinally C. albicans-colonized mice. METHODS AND MATERIALS: BALB/c mice, treated with antibacterial antibiotics to decontaminate indigenous intestinal bacterial flora, were inoculated intragastrically with C. albicans. The mice, in which C. albicans grows intestinally, were administered prednisolone to induce temporary immunosuppression. The Candida growth in their intestinal tract and their antibody response to Candida were examined. RESULTS: Antibiotic treatment allowed establishment of C. albicans gastrointestinal colonization, but did not cause subsequent systemic dissemination of C. albicans in all the animals. When these animals received an additional treatment with prednisolone, they showed a significantly higher population of C. albicans in their feces than those of animals treated with antibiotics alone, and the organisms were recovered even from their kidney. This systemic dissemination by C. albicans appeared to be temporal, because all the mice survived without any symptoms for more than 2 months. Examination of the serum titers of total immunoglobulin (Ig)E antibodies and specific IgE and IgG antibodies against Candida antigens demonstrated that titers of total IgE increased, partially by day 14 and clearly at day 27, in prednisolone-treated Candida-colonized mice. Without prednisolone treatment, an increment of the serum titer was scarcely observed. By day 27, corresponding to the increase of total IgE, the anti-Candida IgE and IgG titer increased in mice of the prednisolone-treated group. CONCLUSION: Administration of prednisolone to Candida-colonized mice can induce production of the IgG, IgE antibodies against Candida antigens, perhaps through temporal systemic dissemination of Candida from the intestinal tract.
Full Text
The Full Text of this article is available as a PDF (211.7 KB).
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Adachi A., Horikawa T., Ichihashi M., Takashima T., Komura A. [Role of Candida allergen in atopic dermatitis and efficacy of oral therapy with various antifungal agents]. Arerugi. 1999 Jul;48(7):719–725. [PubMed] [Google Scholar]
- Akiyama K., Shida T., Yasueda H., Mita H., Yanagihara Y., Hasegawa M., Maeda Y., Yamamoto T., Takesako K., Yamaguchi H. Allergenicity of acid protease secreted by Candida albicans. Allergy. 1996 Dec;51(12):887–892. doi: 10.1111/j.1398-9995.1996.tb04489.x. [DOI] [PubMed] [Google Scholar]
- Bäck O., Scheynius A., Johansson S. G. Ketoconazole in atopic dermatitis: therapeutic response is correlated with decrease in serum IgE. Arch Dermatol Res. 1995;287(5):448–451. doi: 10.1007/BF00373427. [DOI] [PubMed] [Google Scholar]
- Hirano T., Miyajima H., Kitagawa H., Watanabe N., Azuma M., Taniguchi O., Hashimoto H., Hirose S., Yagita H., Furusawa S. Studies on murine IgE with monoclonal antibodies. I. Characterization of rat monoclonal anti-IgE antibodies and the use of these antibodies for determinations of serum IgE levels and for anaphylactic reactions. Int Arch Allergy Appl Immunol. 1988;85(1):47–54. [PubMed] [Google Scholar]
- Kimura M., Tsuruta S., Yoshida T. IFN-gamma plays a dominant role in upregulation of Candida-specific IgE synthesis in patients with atopic dermatitis. Int Arch Allergy Immunol. 2000 Jul;122(3):195–199. doi: 10.1159/000024397. [DOI] [PubMed] [Google Scholar]
- Kobayashi H., Shibata N., Mitobe H., Ohkubo Y., Suzuki S. Structural study of phosphomannan of yeast-form cells of Candida albicans J-1012 strain with special reference to application of mild acetolysis. Arch Biochem Biophys. 1989 Aug 1;272(2):364–375. doi: 10.1016/0003-9861(89)90230-0. [DOI] [PubMed] [Google Scholar]
- Nermes M., Savolainen J., Kalimo K., Lammintausta K., Viander M. Determination of IgE antibodies to Candida albicans mannan with nitrocellulose-RAST in patients with atopic diseases. Clin Exp Allergy. 1994 Apr;24(4):318–323. doi: 10.1111/j.1365-2222.1994.tb00241.x. [DOI] [PubMed] [Google Scholar]
- Okubo Y., Ichikawa T., Suzuki S. Relationship between phosphate content and immunochemical properties of subfractions of bakers' yeast mannan. J Bacteriol. 1978 Oct;136(1):63–68. doi: 10.1128/jb.136.1.63-68.1978. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Petitpierre M., Gumowski P., Girard J. P. Irritable bowel syndrome and hypersensitivity to food. Ann Allergy. 1985 Jun;54(6):538–540. [PubMed] [Google Scholar]
- Savolainen J., Kortekangas-Savolainen O., Nermes M., Viander M., Koivikko A., Kalimo K., Terho E. O. IgE, IgA, and IgG responses to common yeasts in atopic patients. Allergy. 1998 May;53(5):506–512. doi: 10.1111/j.1398-9995.1998.tb04088.x. [DOI] [PubMed] [Google Scholar]
- Savolainen J., Lammintausta K., Kalimo K., Viander M. Candida albicans and atopic dermatitis. Clin Exp Allergy. 1993 Apr;23(4):332–339. doi: 10.1111/j.1365-2222.1993.tb00331.x. [DOI] [PubMed] [Google Scholar]
- Tansho Shigeru, Ab Shigeru, Mizutani Shigetoshi, Ono Yasuo, Takesako Kazutoh, Yamaguchi Hideyo. Protection of mice from lethal endogenous Candida albicans infection by immunization with Candida membrane antigen. Microbiol Immunol. 2002;46(5):307–311. doi: 10.1111/j.1348-0421.2002.tb02700.x. [DOI] [PubMed] [Google Scholar]
- Uchida K., Yamaguchi H., Shibuya K. [The therapeutic effects of itraconazole, a new triazole antifungal agent, for experimental fungal infections]. Jpn J Antibiot. 1991 May;44(5):588–599. [PubMed] [Google Scholar]